EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible…
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed…
NEW DELHI, Oct. 14, 2025 /PRNewswire/ -- Philip Morris International (PMI) recently hosted the Technovation event in Dubai, focusing on improving…
Leading supply chain publication honors end-to-end demand and production planning project at largest privately held ice cream manufacturer in the…
CHICAGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to…
DUBAI, UAE, Oct. 2, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has listed DoubleZero (2Z),…
Report charts the organization's milestones on its path to improving the wellbeing of people and the planet. GRAND RAPIDS, Mich.,…
September 05, 2025 16:45 ET | Source: Helios Alliance Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance,…